Vimarsana
Biggest News Aggregation in the World

Page 7 - Life Sciences Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Sciences Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Sciences Group Today - Breaking & Trending Today

Here's Why SELLAS Life Sciences Group (NASDAQ:SLS) Must Use Its Cash Wisely - Vimarsana News

Here's Why SELLAS Life Sciences Group (NASDAQ:SLS) Must Use Its Cash Wisely

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Source: yahoo.com
Sellas Life Sciences Reports Positive Trial Results - Vimarsana News

Sellas Life Sciences Reports Positive Trial Results

By Ben Glickman Sellas Life Sciences Group said Wednesday its Phase 1 trial of its leading clinical candidate showed positive results. The New York-based...

Galinpepimut-S Plus Nivolumab Provides Survival Benefits With Acceptable Safety in Mesothelioma - Vimarsana News

Galinpepimut-S Plus Nivolumab Provides Survival Benefits With Acceptable Safety in Mesothelioma

The combination of galinpepimut-S and nivolumab provided positive survival outcomes with an acceptable safety profile in patients with malignant pleural mesothelioma who were refractory to or relapsed after at least 1 line of standard treatment.

SELLAS Life Sciences Group (NASDAQ:SLS) Trading 4.2% Higher - Vimarsana News

SELLAS Life Sciences Group (NASDAQ:SLS) Trading 4.2% Higher

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS – Get Rating)’s stock price traded up 4.2% on Thursday . The company traded as high as $1.78 and last traded at $1.72. 248,797 shares changed hands during trading, a decline of 24% from the average session volume of 326,349 shares. The stock had previously closed at $1.65. Analyst […]

SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 0.6% - Vimarsana News

SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 0.6%

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS – Get Rating)’s stock price traded down 0.6% on Wednesday . The company traded as low as $1.66 and last traded at $1.72. 137,316 shares changed hands during mid-day trading, a decline of 61% from the average session volume of 354,253 shares. The stock had previously closed at $1.73. […]